Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05p -5.41% 0.875p 0.85p 0.90p 0.925p 0.875p 0.925p 14,251,764 13:29:51
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.2 -0.0 - 23.15

Sareum (SAR) Latest News

More Sareum News
Sareum Takeover Rumours

Sareum (SAR) Share Charts

1 Year Sareum Chart

1 Year Sareum Chart

1 Month Sareum Chart

1 Month Sareum Chart

Intraday Sareum Chart

Intraday Sareum Chart

Sareum (SAR) Discussions and Chat

Sareum Forums and Chat

Date Time Title Posts
20/10/201712:06Sareum 2015 2,221
22/8/201719:18Sareum 2016722
12/12/201612:19SAR Sareum Drug Discovery Co.15,853
26/4/201618:292012 Sareum Unleashed4,546
20/4/201609:23SAR news is on its way. fasten your seatbelts!172

Add a New Thread

Sareum (SAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:28:470.891,000,0008,940.00O
15:26:420.8932,159287.50O
15:22:150.8999,273887.50O
15:15:290.8934,843311.50O
15:14:280.871,000,0008,677.00O
View all Sareum trades in real-time

Sareum (SAR) Top Chat Posts

DateSubject
20/10/2017
09:20
Sareum Daily Update: Sareum Holdings is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 0.93p.
Sareum Holdings has a 4 week average price of 0.85p and a 12 week average price of 0.73p.
The 1 year high share price is 1.25p while the 1 year low share price is currently 0.70p.
There are currently 2,645,223,988 shares in issue and the average daily traded volume is 15,055,976 shares. The market capitalisation of Sareum Holdings is £23,145,709.90.
20/10/2017
12:02
jaknife: spacedust, I'm waiting for someone to give a sensible explanation as to why they think the current share price is justified. That's a real question rather than your hypothetical one. JakNife
20/10/2017
10:35
jaknife: spacedust, I think that SAR is overvalued. Simples. I am therefore short. Simples. People buying shares today are effectively paying £25m to buy a piggybank with £2.3m in and the possibility that the company might magic more cash out of thin air in the future. Looking back the company has churned out losses every year apart from this year when it has received a special one-off non-recurring lump sum. Next year it's going to make a loss and some of that cash will disappear, hence this time next year it will be a piggbank with, say ,only £1.3m in. Buying shares in Sareum is bonkers, they're worth 10% of the current share price and this time next year they'll be worth even less. SELL JakNife
19/10/2017
20:32
goose feathers: ho hop ho what have we here share price will collapse the company must be taken out of this mitchells hands the company cashflow from chk 1 must be used for shareholders or bio trust investment - MUST NOT BE GIVEN TO MITCHELL - VOTE HIM OFF THE DIRECTORS NO DETAILS GIVEN IN THE ANNUAL REPORT JUST VAGUENESS NEXT YEAR UPDATES IS THIS BLUFFERS TRIED AND TESTED HALF YEARLY ANNOUNCEMENT FOR 14 YEARS READ THE PREVIOUS REPORTS TEN OUT TEN CHINA FAILURE TYK 23 FAILURE LEAD OPTIMISATION NOWHERE CLINICAL TRIAL APPLICATION NOTHING LUPUS REPORT NOTHING LEADING ACADEMIC CENTRES HO HO HO AND STILL SYNTHESING AH F~~K OFF TIM MITCHELL YOU CANNOT TEL THE TRUTH JUST LOOK AT YOUR VIDEO PRESENTATION YOU PROMISED A DEAL STAND BY THAT STATEMENT 5 YEARS AGO YOU DID NOT SIGN A DEAL AT ANY TIME IT WAS CRUK - THEY DID IT NOT YOU AND YOU ARE MILKING THE CASH YOU WILL BE HUMILIATED AT THE NEXT AGM
19/10/2017
15:33
jaknife: Are we all reading the same results? 2.75 billion shares in issue share price 0.925p Market cap £25.4m So the market values the company at over £25m but if you look inside the box it's got less than a tenth of that number in cash. The income this year is a lump sum one-off and losses are to be expected for future years. The share price should fall 90% really.
11/10/2017
12:59
cerrito: I see that Sierra making another presentation and have been rewarded with their share price at a one year high. I am assuming that the recent increase in SAR’s price and trading volumes have been as a result of SRA’s increased profile. We will have the prelims in 2/3 weeks time-I need to say I would be pleasantly surprised if there has been a meaningful advance on Aurora and do not know what to expect on the two TYK programmes Sierra Oncology to Present at the 2017 BIO Investor Forum - "Beyond PARP - Next Generation DDR Therapeutics" scheduled for 11:00 am PT on October 17, 2017 - VANCOUVER, Oct 11, 2017 /CNW/ - Sierra Oncology, Inc. (NASDAQ: SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled "Beyond PARP – Next Generation DDR Therapeutics" at the 2017 BIO Investor Forum in San Francisco. The presentation is scheduled for 11:00 am PT on Tuesday, October 17th. A live audio webcast and archive of the presentation will be accessible through www.sierraoncology.com
26/9/2017
08:46
waleoilbeefhooked: Greyseal ................If you are implying that present share price performance is being affected by the prospect of results "ahead of expectations" then I think you are potentially misleading readers of this thread. In the scheme of things anything "ahead of expectations" will be welcome but insignificant. The real price mover here is how well clinical trials are going. All IMHO, WOBH
09/5/2017
22:37
goose feathers: Ho ho ho what have we here ,share price falling, no directors buying , half million pounds in salaries, no details of Cro in research @China from me sales jock strap(tothy,or hoppyhophopkirky).... Oh DR TIM is presenting , when are you going to say something Mitchell and then do it, ....... S'ssssslippage in CHina. , ssssssslippage in USA, ...every year for 14 years , ......I stand by that statement Dr Tim ......when you going to deliver and produce......this year. No way on thk2 .next year...you will announce that China is a dead duck,...oops sorry to all my feathery friends. But it will be so .....just look at and listen to the silence from the half £500000 per year.,lotto salary directors...the shambles of sareum continues.
01/5/2017
20:38
goose feathers: Ho ho ho what have we here, 2.43 in The Morning ( ha ha ha ha ) me sales jock strap wants to declare someone as desperate, but is unable being the great researcher to ,state the name of the CRO in China or explain the 28 pence ,a cool 31 times the current share price , .....but it is even more interesting late night early in the morning , and just by chance on the other bb that chap also a great researcher ,in built nomad on giving the SAreum view, .....he puts his nursery rhyme respond at 2.29 in the morning, ......both exhibit the same narcissistic mannerisms .....just by chance they post within minutes. Under different names,......oh and where or where was toth2 ...( one and same person ) glaringly obvious. Hoppppy hop hop and mesalesstockingtops .
06/12/2016
20:04
goose feathers: Why are there no independent directors. The company can afford it? So why not? Who owns the patents to Chk1. Not sareum,and not sareum shareholders Aurora,patents shareholders or Mr reader the man ,no director who went on proactive and failed to tell the truth and nothing but the truth, just how did they manage to avoid a question about Aurora overdue clinical trial- because it was a pathetic pr interview. And reader did not want the question asked cos he knew the answer which was price sensitive ,. Tyk2 ,where is the lead optimisation promised,another porky ,never mind the " institutions sniffing around". Where are these rampers coming from,all delighted by a share that has a share graph which tells the whole story. Indepent directors, not here cos I'd want to know about the statements made by scientific big piece of pie Mitchell, about deals. And the statements that were not made in the last 12 months. The share price will fall further ,no news is good news,no Not with the scientific Tim and read me my patents reader,and once again no one will trust them.share price has further to fall.
10/3/2016
12:57
duxy786: 10/03/2016 12:55pm UK Regulatory (RNS & others) Sareum (LSE:SAR) Intraday Stock Chart Today : Thursday 10 March 2016 Click Here for more Sareum Charts. TIDMSAR RNS Number : 7178R Sareum Holdings PLC 10 March 2016 SAREUM HOLDINGS PLC ("Sareum") Share price movement Sareum, the specialist cancer drug discovery and development business, notes the recent movement in its share price and the Board would like to advise the market that, having published its interim results for the period ended 31 December 2015 on 24 February 2016, it is not aware of any undisclosed reason for this rise. Sareum Holdings plc
Sareum share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20171020 16:14:20